The FDA has granted premarket approval to a test that assesses a patient’s viral load of cytomegalovirus (CMV), the most common and important viral infection in recipients of solid organ transplants.

Assay will help monitor the effects of antiviral therapy in organ transplant patients. Roche’s Cobas® AmpliPrep/Cobas TaqMan® CMV test for evaluating cytomegalovirus (CMV) load received FDA premarket ...

Cytomegalovirus (CMV) is a ubiquitous infection and congenital CMV (cCMV) infection is the most common non-genetic cause of hearing loss in infants and children. However, most pregnant women and women ...

In the United States, over 40,000 transplantations are performed annually. Ensuring post-transplant success requires diligent monitoring of infectious diseases that are associated with a wide range of ...